IRIS
POROTTO, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.179
AS - Asia 2.201
NA - Nord America 2.170
SA - Sud America 494
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 34
OC - Oceania 1
Totale 9.199
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.043
US - Stati Uniti d'America 2.128
SG - Singapore 920
IE - Irlanda 546
BR - Brasile 425
CN - Cina 395
HK - Hong Kong 309
KR - Corea 220
VN - Vietnam 212
GB - Regno Unito 172
UA - Ucraina 125
IT - Italia 100
GR - Grecia 58
DE - Germania 54
AR - Argentina 36
IN - India 35
BD - Bangladesh 28
FR - Francia 17
CA - Canada 16
ID - Indonesia 14
EC - Ecuador 12
FI - Finlandia 12
IQ - Iraq 11
MX - Messico 11
ZA - Sudafrica 11
JP - Giappone 10
SA - Arabia Saudita 8
UZ - Uzbekistan 8
TR - Turchia 7
AT - Austria 6
CO - Colombia 6
MA - Marocco 6
NL - Olanda 6
CZ - Repubblica Ceca 5
EG - Egitto 5
ES - Italia 5
PL - Polonia 5
PY - Paraguay 5
TN - Tunisia 5
CL - Cile 4
CR - Costa Rica 4
PK - Pakistan 4
SE - Svezia 4
AL - Albania 3
BE - Belgio 3
BY - Bielorussia 3
CH - Svizzera 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
MY - Malesia 3
VE - Venezuela 3
GT - Guatemala 2
HN - Honduras 2
LK - Sri Lanka 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
MV - Maldive 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 9.079
Salva come PNG Salva come JPEG
Città #
Moscow 1.162
Dublin 519
Santa Clara 403
Singapore 372
San Jose 353
Hong Kong 308
Jacksonville 235
Seoul 220
Chandler 96
New York 95
Ashburn 85
Princeton 76
Roxbury 76
Ho Chi Minh City 73
Beijing 64
Medford 63
Hanoi 51
Hefei 41
São Paulo 41
Des Moines 33
Menlo Park 32
Dallas 23
Jinan 21
Wilmington 21
Munich 20
The Dalles 20
Nanjing 19
Cambridge 18
Los Angeles 17
Rio de Janeiro 17
Shenyang 16
Bengaluru 15
Redwood City 14
Naples 13
Orem 13
Cagliari 12
Memphis 12
Belo Horizonte 10
Caserta 10
Norwalk 10
Nuremberg 10
Rome 10
Tianjin 10
Curitiba 9
Atlanta 8
Brasília 8
Da Nang 8
Fairfield 8
Haiphong 8
Montreal 8
Quito 8
Turku 8
Boardman 7
Boston 7
Hebei 7
Mountain View 7
Ningbo 7
Tashkent 7
Biên Hòa 6
Bremen 6
Caxias do Sul 6
Guangzhou 6
Haikou 6
Hangzhou 6
Porto Alegre 6
Redmond 6
San Francisco 6
Tokyo 6
Zhengzhou 6
Ann Arbor 5
Changsha 5
Falkenstein 5
Juiz de Fora 5
Lanzhou 5
Mexico City 5
Shanghai 5
Taiyuan 5
Taizhou 5
Avellino 4
Baghdad 4
Brooklyn 4
Buffalo 4
Campinas 4
Columbus 4
Dhaka 4
Goiânia 4
Guarulhos 4
Hải Dương 4
Johannesburg 4
Manchester 4
Milan 4
Nanchang 4
Quận Một 4
Riyadh 4
Salvador 4
São Gonçalo 4
Thái Bình 4
Vienna 4
Warsaw 4
Woodbridge 4
Totale 5.043
Salva come PNG Salva come JPEG
Nome #
Analysis of a subacute sclerosing panencephalitis (SSPE) Genotype B3 virus from the 2009/10 South African measles epidemic shows hyperfusogenic F proteins contribute to measles virus infection in the brain 183
A rapid high-throughput assay for the identification of neutralizing antibodies and antiviral molecules against SARS-CoV-2 virus 155
Human parainfluenza virus evolution during lung infection of immunocompromised humans promotes viral persistence 154
Effective in Vivo Targeting of Influenza Virus through a Cell-Penetrating/Fusion Inhibitor Tandem Peptide Anchored to the Plasma Membrane 153
Measles virus bearing MIBE-derived fusion protein is pathogenic after infection via the respiratory route 148
Effects of single α-to-β residue replacements on recognition of an extended segment in a viral fusion protein 144
Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection 137
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum 135
Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus 132
Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides 129
A broad-spectrum antiviral targeting entry of enveloped viruses 128
Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent 126
A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity 124
A three-dimensional model of human lung development and disease from pluripotent stem cells 124
Antiviral activity of nitazoxanide against Morbillivirus infections 119
A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism 119
Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue 117
Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals 117
Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro 116
Authentic modeling of human respiratory virus infection in human pluripotent stem cell-derived lung organoids 116
A neutralizing antibody prevents postfusion transition of measles virus fusion protein 112
A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity 111
Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus 111
Antiviral Lipopeptide-Cell Membrane Interaction Is Influenced by PEG Linker Length 110
A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo 109
Biophysical properties and antiviral activities of measles fusion protein derived peptide conjugated with 25-hydroxycholesterol 109
Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement 107
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia 104
Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus 102
Molecular determinants of antiviral potency of paramyxovirus entry inhibitors 100
Fatal measles virus infection prevented by brain-penetrant fusion inhibitors 98
The pH-sensitive action of cholesterol-conjugated peptide inhibitors of influenza virus 98
Viral entry properties required for fitness in humans are lost through rapid genomic change during viral isolation 96
Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection 96
Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain 94
Identification of a region in the stalk domain of the Nipah virus receptor binding protein that is critical for fusion activation 93
Paramyxovirus receptor-binding molecules: Engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site 93
Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II 93
Fusion inhibitory lipopeptides engineered for prophylaxis of nipah virus in primates 93
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets 93
Measles fusion machinery is dysregulated in neuropathogenic variants 91
Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model 90
Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides 90
Mechanism of interference mediated by human parainfluenza virus type 3 infection 90
Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism 89
Characterization of a SARS-CoV-2 Omicron BA.5 direct-contact transmission model in hamsters 88
Inhibition of parainfluenza virus type 3 and newcastle disease virus hemagglutinin-neuraminidase receptor binding: Effect of receptor avidity and steric hindrance at the inhibitor binding sites 88
Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment 87
Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein 87
Viral entry inhibitors targeted to the membrane site of action 87
Structure-Stability-Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles 87
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection 86
Spring-loaded model revisited: Paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein 86
Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo 85
Features of circulating parainfluenza virus required for growth in human airway 85
Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy 85
The in vitro multilineage differentiation and maturation of lung and airway cells from human pluripotent stem cell-derived lung progenitors in 3D 85
Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus 84
SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19 83
In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence 83
Mechanism of fusion triggering by human parainfluenza virus type III: Communication between viral glycoproteins during entry 83
Inhibition of coronavirus entry in vitro and ex vivo by a lipid-conjugated peptide derived from the sars-cov-2 spike glycoprotein hrc domain 83
Inhibition of Measles Viral Fusion Is Enhanced by Targeting Multiple Domains of the Fusion Protein 83
Intermediates in SARS-CoV-2 spike-mediated cell entry 82
Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance 81
Negative staining of proteins in polyacrylamide gels with methyl trichloroacetate 81
Human parainfluenza virus type 3 HN-receptor interaction: Effect of 4-guanidino-neu5Ac2en on a neuraminidase-deficient variant 81
Human parainfluenza virus infection of the airway epithelium: Viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity 81
Inhibition of Nipah Virus Infection In Vivo: Targeting an early stage of paramyxovirus fusion activation during viral entry 81
Inhibition of Hendra virus fusion 80
Unity in diversity: shared mechanism of entry among paramyxoviruses 80
Measles virus fusion machinery activated by sialic acid binding globular domain 79
Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion 79
The second receptor binding site of the globular head of the newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion 79
Kinetic dependence of paramyxovirus entry inhibition 78
Hijacking the fusion complex of human parainfluenza virus as an antiviral strategy 78
Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor 77
In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age 77
Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo 77
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure infection 76
Engineering Protease-Resistant Peptides to Inhibit Human Parainfluenza Viral Respiratory Infection 76
Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets 75
Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces 75
Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds 74
Regulation of paramyxovirus fusion activation, the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state 74
Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery 74
Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection 71
Modulation of Oncogenic DBL Activity by Phosphoinositol Phosphate Binding to Pleckstrin Homology Domain 70
How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody 69
Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir) 69
Early Permissiveness of Central Nervous System Cells to Measles Virus Infection Is Determined by Hyperfusogenicity and Interferon Pressure 65
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity 63
Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern 63
Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments 61
Human parainfluenza virus 3 field strains undergo extracellular fusion protein cleavage to activate entry 54
Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development 54
Subnanometer structure of an enveloped virus fusion complex on viral surface reveals new entry mechanisms 45
Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate 37
Totale 9.199
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022455 0 1 5 66 159 4 5 11 14 1 33 156
2022/2023673 80 1 0 7 57 36 0 33 426 3 14 16
2023/2024350 25 5 10 4 142 64 1 3 1 2 14 79
2024/20251.493 23 100 4 10 192 196 89 102 168 418 110 81
2025/20265.316 242 319 258 366 379 2.812 170 344 246 95 68 17
2026/2027113 46 67 0 0 0 0 0 0 0 0 0 0
Totale 9.199